{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:26:35Z","timestamp":1790612795419,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xcrm.2024.101885","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:34:23Z","timestamp":1736177663000},"page":"101885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Delivery of genetic medicines for muscular dystrophies"],"prefix":"10.1016","volume":"6","author":[{"given":"Yulia","family":"Chulanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Breier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8238-0673","authenticated-orcid":false,"given":"Dan","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101885_bib1","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101885_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.xcrm.2024.101885_bib13","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1002\/jcp.27907","article-title":"Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review.","volume":"234","author":"Taghizadeh","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.xcrm.2024.101885_bib14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101885_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s13311-018-00679-z","article-title":"Myotonic Dystrophies: Targeting Therapies for Multisystem Disease","volume":"15","author":"LoRusso","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.xcrm.2024.101885_bib17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.nmd.2021.08.003","article-title":"X-linked myotubular myopathy","volume":"31","author":"Lawlor","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.xcrm.2024.101885_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.xcrm.2024.101885_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0168-9525(01)02245-4","article-title":"The myotubularin family: From genetic disease to phosphoinositide metabolism","volume":"17","author":"Laporte","year":"2001","journal-title":"Trends Genet."},{"key":"10.1016\/j.xcrm.2024.101885_bib19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/jcm10071375","article-title":"Recent Progress in Oculopharyngeal Muscular Dystrophy","volume":"10","author":"Yamashita","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib2","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","article-title":"The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein","volume":"53","author":"Koenig","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101885_bib4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40265-023-01943-z","article-title":"Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis","volume":"83","author":"Nie","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.xcrm.2024.101885_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/liv.15090","article-title":"Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study","volume":"42","author":"Ventura","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.xcrm.2024.101885_bib6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101885_bib8","article-title":"CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2024.101885_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","article-title":"Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy","volume":"27","author":"Dzierlega","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/hum.2023.026","article-title":"The Future of Exon Skipping for Duchenne Muscular Dystrophy","volume":"34","author":"Aartsma-Rus","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.coph.2005.07.001","article-title":"Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers","volume":"5","author":"Amantana","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101885_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cphy.c140068","article-title":"Satellite cells and skeletal muscle regeneration","volume":"5","author":"Dumont","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.xcrm.2024.101885_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mus.22094","article-title":"Structure and function of the skeletal muscle extracellular matrix","volume":"44","author":"Gillies","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.xcrm.2024.101885_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2024.101885_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jmor.21088","article-title":"Diversity of extracellular matrix morphology in vertebrate skeletal muscle","volume":"281","author":"Sleboda","year":"2020","journal-title":"J.\u00a0Morphol."},{"key":"10.1016\/j.xcrm.2024.101885_bib24","doi-asserted-by":"crossref","first-page":"33875","DOI":"10.1074\/jbc.M011553200","article-title":"Extracellular Glycosaminoglycans Modify Cellular Trafficking of Lipoplexes and Polyplexes","volume":"276","author":"Ruponen","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101885_bib25","unstructured":"Saxton, A., Tariq, M., and Bordoni, B. (2022). Anatomy, Thorax, Cardiac Muscle."},{"key":"10.1016\/j.xcrm.2024.101885_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/15419061.2014.905928","article-title":"Cell junctions in the specialized conduction system of the heart","volume":"21","author":"Mezzano","year":"2014","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.xcrm.2024.101885_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11886-020-01289-y","article-title":"Role of Mononuclear Cardiomyocytes in Cardiac Turnover and Regeneration","volume":"22","author":"Becker","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.xcrm.2024.101885_bib28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of Cell Generation and Turnover in the Human Heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101885_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/jvi.45.2.555-564.1983","article-title":"Nucleotide sequence and organization of the adeno-associated virus 2 genome","volume":"45","author":"Srivastava","year":"1983","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101885_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm0397-306","article-title":"Recombinant adeno-associated virus for muscle directed gene therapy","volume":"3","author":"Fisher","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gt.2010.141","article-title":"MicroRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors","volume":"18","author":"Geisler","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.mt.6300022","article-title":"Phenotypic correction of \u03b1-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector","volume":"15","author":"Fougerousse","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2017.12.005","article-title":"Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD","volume":"8","author":"Wallace","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101885_bib34","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/mt.2011.153","article-title":"AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy","volume":"19","author":"Bortolanza","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/pathophysiology28020016","article-title":"Current and future therapeutic strategies for limb girdle muscular dystrophy type r1: Clinical and experimental approaches","volume":"28","author":"\u015eahin","year":"2021","journal-title":"Pathophysiology"},{"key":"10.1016\/j.xcrm.2024.101885_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtn.2021.02.017","article-title":"BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy","volume":"24","author":"Strings-Ufombah","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2024.101885_bib37","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.ymthe.2020.10.005","article-title":"Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1","volume":"28","author":"Marsh","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","article-title":"In\u00a0Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy","volume":"19","author":"Kwon","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101885_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101885_bib40","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ymthe.2019.06.012","article-title":"AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice","volume":"27","author":"Nance","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.38","article-title":"Adeno-associated viral vectors do not efficiently target muscle satellite cells","volume":"1","author":"Arnett","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101885_bib54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/d41573-023-00103-y","article-title":"FDA approves first gene therapy for Duchenne muscular dystrophy, despite internal objections","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2024.101885_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2024.101885_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202000309","article-title":"Development of Highly Efficient Dual-AAV Split Adenosine Base Editor for In\u00a0Vivo Gene Therapy","volume":"4","author":"Chen","year":"2020","journal-title":"Small Methods"},{"key":"10.1016\/j.xcrm.2024.101885_bib59","article-title":"Efficient precise in\u00a0vivo base editing in adult dystrophic mice","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib69","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1566523223666230407091317","article-title":"Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease","volume":"23","author":"Eren","year":"2023","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib70","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.gt.3302505","article-title":"Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin","volume":"12","author":"Li","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib74","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","article-title":"Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery","volume":"186","author":"Hindi","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101885_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.xcrm.2024.101885_bib89","first-page":"387","article-title":"In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles","volume":"25","author":"Gao","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.xcrm.2024.101885_bib97","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12265-018-9826-9","article-title":"Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice","volume":"11","author":"Su","year":"2018","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.xcrm.2024.101885_bib98","first-page":"10","article-title":"Purification and transplantation of myogenic progenitor cell derived exosomes to improve cardiac function in duchenne muscular dystrophic mice","volume":"146","author":"Su","year":"2019","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.xcrm.2024.101885_bib99","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","article-title":"Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy","volume":"10","author":"Aminzadeh","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101885_bib103","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1021\/acsnano.2c12261","article-title":"Nonviral In\u00a0Vivo Delivery of CRISPR-Cas9\u00a0Using Protein-Agnostic, High-Loading Porous Silicon and Polymer Nanoparticles","volume":"17","author":"Fletcher","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2024.101885_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05166-0","article-title":"In\u00a0vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides","volume":"13","author":"Cohen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2024.101885_bib111","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omtm.2019.10.002","article-title":"Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy","volume":"15","author":"Guha","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101885_bib114","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1089\/hum.2015.023","article-title":"High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline","volume":"26","author":"Fan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib121","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/hum.2006.115","article-title":"Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle","volume":"18","author":"Vigen","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib115","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/hum.2019.006","article-title":"Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion","volume":"30","author":"Mendell","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12100964","article-title":"Microbubbles and nanobubbles with ultrasound for systemic gene delivery","volume":"12","author":"Endo-Takahashi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2024.101885_bib124","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2967\/jnumed.109.074443","article-title":"Delivery of Na\/I symporter gene into skeletal muscle using nanobubbles and ultrasound: Visualization of gene expression by PET","volume":"51","author":"Watanabe","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib125","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/pharmaceutics15061665","article-title":"Development of a Gene and Nucleic Acid Delivery System for Skeletal Muscle Administration via Limb Perfusion Using Nanobubbles and Ultrasound","volume":"15","author":"Sekine","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2024.101885_bib42","series-title":"Dystrophin Immunity in Duchenne\u2019s Muscular Dystrophy","year":"2010"},{"key":"10.1016\/j.xcrm.2024.101885_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1089\/hum.2021.243","article-title":"Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States","volume":"33","author":"Khatri","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib44","first-page":"442","article-title":"Adeno-associated virus vector integration Current Opinion in Molecular Therapeutics","volume":"11","author":"Deyle","year":"2009","journal-title":"Current Opin. Mole. Therapeu."},{"key":"10.1016\/j.xcrm.2024.101885_bib45","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/mt.2012.157","article-title":"AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence","volume":"20","author":"Wang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2020.12.031","article-title":"Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","article-title":"Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors","volume":"8","author":"Donsante","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib50","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib51","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne\u2019s Muscular Dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JND-221639","article-title":"Meeting Report: 2022 Muscular Dystrophy Association Summit on \u201cSafety and Challenges in Gene Transfer Therapy.\u201d","volume":"10","author":"Lek","year":"2023","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.xcrm.2024.101885_bib53","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children with Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2024.101885_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221149781","article-title":"Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy","volume":"16","author":"Goedeker","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.xcrm.2024.101885_bib58","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2024.101885_bib63","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101885_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4704","article-title":"Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"8","author":"El Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101885_bib65","article-title":"Ancestral library identifies conserved reprogrammable liver motif on AAV capsid","volume":"3","author":"Zinn","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031551","article-title":"Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2\/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy","volume":"23","author":"Matsuzaka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101885_bib68","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101885_bib71","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune Responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2009.253","article-title":"Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression","volume":"18","author":"Kimura","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jgm.649","article-title":"Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors","volume":"7","author":"MacKenzie","year":"2005","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.xcrm.2024.101885_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1033982","article-title":"The effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signaling pathway on organ inflammatory injury and fibrosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101885_bib76","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The Capsids of HIV-1 and HIV-2 Determine Immune Detection of the Viral cDNA by the Innate Sensor cGAS in Dendritic Cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101885_bib77","first-page":"272","article-title":"In\u00a0vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"1979","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101885_bib78","article-title":"Lentiviral vectors can be used for full-length dystrophin gene therapy","volume":"7","author":"Counsell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101885_bib79","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.xcrm.2024.101885_bib80","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","article-title":"Targeted nanomedicine: Lessons learned and future directions","volume":"355","author":"Veiga","year":"2023","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.xcrm.2024.101885_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102129","article-title":"Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy","volume":"14","author":"Godbout","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2024.101885_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092291","article-title":"Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery","volume":"15","author":"Du","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2024.101885_bib85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in\u00a0vivo delivery screening HHS Public Access","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.xcrm.2024.101885_bib86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib87","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib90","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101885_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114954","article-title":"Biogenesis and function of extracellular vesicles in pathophysiological processes of skeletal muscle atrophy","volume":"198","author":"Wang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101885_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/biology12010110","article-title":"Extracellular Vesicles: New Classification and Tumor Immunosuppression","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.xcrm.2024.101885_bib93","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","article-title":"Extracellular vesicles: The next generation in gene therapy delivery","volume":"31","author":"Cecchin","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib94","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40259-020-00434-x","article-title":"Designer Exosomes: A New Platform for Biotechnology Therapeutics","volume":"34","author":"Jafari","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.xcrm.2024.101885_bib95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","article-title":"RNAi delivery by exosome-mimetic nanovesicles\u00a0\u2013 Implications for targeting c-Myc in cancer","volume":"102","author":"Lunavat","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2024.101885_bib96","article-title":"PROKR1 delivery by cell-derived vesicles restores the myogenic potential of Prokr1-deficient C2C12 myoblasts","volume":"37","author":"Zhang","year":"2021","journal-title":"Nanomedicine."},{"key":"10.1016\/j.xcrm.2024.101885_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14957-y","article-title":"Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping","volume":"11","author":"Gee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib101","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/03639049809108571","article-title":"Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers","volume":"24","author":"Quintanar-Guerrero","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.xcrm.2024.101885_bib102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.21037\/tau-21-723","article-title":"ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD\u00ae) in Asian men with prostate cancer","volume":"11","author":"Malek","year":"2022","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.xcrm.2024.101885_bib104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12951-023-01994-0","article-title":"Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD","volume":"21","author":"Hicks","year":"2023","journal-title":"J.\u00a0Nanobiotechnology"},{"key":"10.1016\/j.xcrm.2024.101885_bib105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.omtn.2017.09.006","article-title":"Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In\u00a0Vitro and in mdx Mice","volume":"9","author":"Wang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2024.101885_bib106","article-title":"Triazine-cored polymeric vectors for antisense oligonucleotide delivery in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Wang","year":"2020","journal-title":"J.\u00a0Nanobiotechnology"},{"key":"10.1016\/j.xcrm.2024.101885_bib108","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in\u00a0vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib109","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.1038\/mtm.2015.39","article-title":"Highly efficient in\u00a0vitro and in\u00a0vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles","volume":"2","author":"Prel","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101885_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in\u00a0vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101885_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.834705","article-title":"Targeting Muscle-Resident Single Cells Through in\u00a0vivo Electro-Enhanced Plasmid Transfer in Healthy and Compromised Skeletal Muscle","volume":"13","author":"Florio","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2024.101885_bib113","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2011.137","article-title":"Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy","volume":"20","author":"Fan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101885_bib117","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/mt.2014.151","article-title":"Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients","volume":"22","author":"Le Guiner","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2008.135","article-title":"Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth","volume":"20","author":"Qiao","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib119","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/hum.2010.160","article-title":"Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA","volume":"22","author":"Wooddell","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hum.2009.133","article-title":"Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection","volume":"21","author":"Zhang","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2024.101885_bib122","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1039\/D0RA08727K","article-title":"Current advances in ultrasound-combined nanobubbles for cancer-targeted therapy: a review of the current status and future perspectives","volume":"11","author":"Su","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.xcrm.2024.101885_bib126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-7374-3_13","article-title":"PMO delivery system using bubble liposomes and ultrasound exposure for Duchenne muscular dystrophy treatment","volume":"1","author":"Negishi","year":"2018","journal-title":"Method. Mole. Biol."},{"key":"10.1016\/j.xcrm.2024.101885_bib127","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/mp4004755","article-title":"Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice","volume":"11","author":"Negishi","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.xcrm.2024.101885_bib128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41587-021-01026-y","article-title":"Deletion and replacement of long genomic sequences using prime editing","volume":"40","author":"Jiang","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101885_bib129","article-title":"Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases","author":"Ferreira da Silva","year":"2023","journal-title":"bioRxiv"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:24:56Z","timestamp":1739337896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124006566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666379124006566"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101885","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of genetic medicines for muscular dystrophies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101885"}}